Rallybio Corporation
RLYB
$0.626
$0.0325.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.80% | 14.53% | 3.68% | 29.38% | 14.68% |
| Total Depreciation and Amortization | -7.14% | -6.67% | -6.25% | -5.88% | -2.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.52% | 8.62% | -10.59% | 16.97% | -11.10% |
| Change in Net Operating Assets | 85.25% | -229.73% | 79.14% | -216.75% | 191.48% |
| Cash from Operations | 17.89% | -3.48% | 27.19% | -30.02% | 32.60% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.61% | 804.45% | -107.08% | 755.35% | -74.71% |
| Cash from Investing | -72.61% | 804.45% | -107.08% | 755.35% | -74.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 95.72% | -- |
| Cash from Financing | -- | -- | 263.64% | -100.21% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -708.90% | 107.67% | -232.00% | 428.86% | 49.35% |